Clinical trial
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
NCT06637904 is registered in ClinicalTrials.gov with Inflammatix as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
- Lead sponsor
- Inflammatix
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 8, 2024
- Completion date
- March 10, 2026
- Enrollment
- 320 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.